Remember the last time when part-time CEO Jackie Fairley did an interview on ****** in mid 2020?
She boasted of Starpharma, and I quote, having ‘deep regulatory knowledge’. This genius CEO, full of hubris then doubled down in an interview with Alan Kohler in early 2021 that TGA regulatory approval of Viraleze should only be a “matter of weeks”.
Sorry to break it to you Jackie, but 16 months have now elapsed since that comment to Alan Kohler. And she now wants us to believe from comments in last week’s interview that Starpharma has never been in a better place.
Basically zero condom sales.
Negligible VivaGel BV sales.
Delayed internal DEP trials with no end in sight.
No resolution of the FDA debacle 3.5 years later.
Viraleze still not TGA approved and still not on the shelves in the UK.
Pull the other one Jackie.
DYOR
Remember the time
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 586785 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |